India’s Bharat Biotech says its COVID-19 vaccine is 81% effective
It was criticised for being rolled out before final trials SAMAA | AFP - Posted: Mar 4, 2021 | Last Updated: 1 month ago SAMAA | AFP Posted: Mar 4, 2021 | Last Updated: 1 month ago
File photo: A health care worker holds a vial of Covaxin. Photo: AFP
Listen to the story
Indian pharmaceutical firm Bharat Biotech said Wednesday its domestically developed vaccine, criticised for being rolled out before final trials, was found in interim late-stage data to have almost 81% efficacy in preventing Covid-19 infection.
Questions had been raised by Indian medical experts about the effectiveness of Bharat Biotech s Covaxin after officials authorised it for emergency use in January even though its Phase 3 trials the last stage before regulatory approval were not complete.
India
Bharat
Astrazeneca-oxford
Narendra-modi
Krishna-ella
Pfizer
Indian-council-for-medical
Bharat-biotech
Indian-council
Medical-research-were
Prime-minister-narendra-modi